Placental anticoagulant protein-l: Measurement in extracellular fluids and cells of the hemostatic system

M. J. Flaherty, S. West, Ronald L Heimark, K. Fujikawa, J. F. Tait

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Placental anticoagulant protein-l (PAP-l), a member of the lipocortin protein family, is a potent in vitro anticoagulant whose in vivo function is unknown. Very low levels of PAP-l were present in plasma of normal volunteers (0 to 5 ng/ml) and in randomly chosen plasma specimens from hospitalized patients (0 to 28 ng/ml). Review of selected hospital records did not reveal any single clinical entity that correlated with plasma levels. PAP-l was also found in amniotic fluid (12 to 107 ng/ml) and in conditioned medium of cultured endothelial cells (49 ± 20 ng/ml). Gel filtration experiments showed that PAP-l was intact and uncomplexed in plasma and amniotic fluid. The protein was fairly abundant intracellularly: 4080 ± 2560 ng/mg total protein in cultured umbilical vein endothelial cells; 178 ± 109 ng/mg in platelets; 564 ± 384 ng/mg in leukocytes; and 8.4 ± 4.3 ng/mg in erythrocytes. The levels of PAP-l increased in platelet-rich plasma after stimulation of platelets with arachidonic acid but not after stimulation with ADP, epinephrine, thrombin, ristocetin, or collagen. These data suggest that PAP-l probably does not function as a circulating natural anticoagulant in normal persons.

Original languageEnglish (US)
Pages (from-to)174-181
Number of pages8
JournalThe Journal of Laboratory and Clinical Medicine
Volume115
Issue number2
StatePublished - 1990
Externally publishedYes

Fingerprint

Pregnancy Proteins
Extracellular Fluid
Hemostatics
Anticoagulants
Fluids
Proteins
Plasmas
Platelets
Amniotic Fluid
Endothelial cells
Blood Platelets
Endothelial Cells
Ristocetin
Annexins
Umbilical Veins
Platelet-Rich Plasma
Hospital Records
Conditioned Culture Medium
Arachidonic Acid
Thrombin

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Placental anticoagulant protein-l : Measurement in extracellular fluids and cells of the hemostatic system. / Flaherty, M. J.; West, S.; Heimark, Ronald L; Fujikawa, K.; Tait, J. F.

In: The Journal of Laboratory and Clinical Medicine, Vol. 115, No. 2, 1990, p. 174-181.

Research output: Contribution to journalArticle

@article{86f67ceac6fb44b9894ef3eb4a227795,
title = "Placental anticoagulant protein-l: Measurement in extracellular fluids and cells of the hemostatic system",
abstract = "Placental anticoagulant protein-l (PAP-l), a member of the lipocortin protein family, is a potent in vitro anticoagulant whose in vivo function is unknown. Very low levels of PAP-l were present in plasma of normal volunteers (0 to 5 ng/ml) and in randomly chosen plasma specimens from hospitalized patients (0 to 28 ng/ml). Review of selected hospital records did not reveal any single clinical entity that correlated with plasma levels. PAP-l was also found in amniotic fluid (12 to 107 ng/ml) and in conditioned medium of cultured endothelial cells (49 ± 20 ng/ml). Gel filtration experiments showed that PAP-l was intact and uncomplexed in plasma and amniotic fluid. The protein was fairly abundant intracellularly: 4080 ± 2560 ng/mg total protein in cultured umbilical vein endothelial cells; 178 ± 109 ng/mg in platelets; 564 ± 384 ng/mg in leukocytes; and 8.4 ± 4.3 ng/mg in erythrocytes. The levels of PAP-l increased in platelet-rich plasma after stimulation of platelets with arachidonic acid but not after stimulation with ADP, epinephrine, thrombin, ristocetin, or collagen. These data suggest that PAP-l probably does not function as a circulating natural anticoagulant in normal persons.",
author = "Flaherty, {M. J.} and S. West and Heimark, {Ronald L} and K. Fujikawa and Tait, {J. F.}",
year = "1990",
language = "English (US)",
volume = "115",
pages = "174--181",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Placental anticoagulant protein-l

T2 - Measurement in extracellular fluids and cells of the hemostatic system

AU - Flaherty, M. J.

AU - West, S.

AU - Heimark, Ronald L

AU - Fujikawa, K.

AU - Tait, J. F.

PY - 1990

Y1 - 1990

N2 - Placental anticoagulant protein-l (PAP-l), a member of the lipocortin protein family, is a potent in vitro anticoagulant whose in vivo function is unknown. Very low levels of PAP-l were present in plasma of normal volunteers (0 to 5 ng/ml) and in randomly chosen plasma specimens from hospitalized patients (0 to 28 ng/ml). Review of selected hospital records did not reveal any single clinical entity that correlated with plasma levels. PAP-l was also found in amniotic fluid (12 to 107 ng/ml) and in conditioned medium of cultured endothelial cells (49 ± 20 ng/ml). Gel filtration experiments showed that PAP-l was intact and uncomplexed in plasma and amniotic fluid. The protein was fairly abundant intracellularly: 4080 ± 2560 ng/mg total protein in cultured umbilical vein endothelial cells; 178 ± 109 ng/mg in platelets; 564 ± 384 ng/mg in leukocytes; and 8.4 ± 4.3 ng/mg in erythrocytes. The levels of PAP-l increased in platelet-rich plasma after stimulation of platelets with arachidonic acid but not after stimulation with ADP, epinephrine, thrombin, ristocetin, or collagen. These data suggest that PAP-l probably does not function as a circulating natural anticoagulant in normal persons.

AB - Placental anticoagulant protein-l (PAP-l), a member of the lipocortin protein family, is a potent in vitro anticoagulant whose in vivo function is unknown. Very low levels of PAP-l were present in plasma of normal volunteers (0 to 5 ng/ml) and in randomly chosen plasma specimens from hospitalized patients (0 to 28 ng/ml). Review of selected hospital records did not reveal any single clinical entity that correlated with plasma levels. PAP-l was also found in amniotic fluid (12 to 107 ng/ml) and in conditioned medium of cultured endothelial cells (49 ± 20 ng/ml). Gel filtration experiments showed that PAP-l was intact and uncomplexed in plasma and amniotic fluid. The protein was fairly abundant intracellularly: 4080 ± 2560 ng/mg total protein in cultured umbilical vein endothelial cells; 178 ± 109 ng/mg in platelets; 564 ± 384 ng/mg in leukocytes; and 8.4 ± 4.3 ng/mg in erythrocytes. The levels of PAP-l increased in platelet-rich plasma after stimulation of platelets with arachidonic acid but not after stimulation with ADP, epinephrine, thrombin, ristocetin, or collagen. These data suggest that PAP-l probably does not function as a circulating natural anticoagulant in normal persons.

UR - http://www.scopus.com/inward/record.url?scp=0025214947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025214947&partnerID=8YFLogxK

M3 - Article

C2 - 2137157

AN - SCOPUS:0025214947

VL - 115

SP - 174

EP - 181

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 2

ER -